Beauty Health Company (The) (SKIN) has a profit margin of -187.71%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2021
Trailing 12 months ending Sep 2021
The latest profit margin for SKIN is -187.71% as of September 2021. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Beauty Health Company (The)'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, SKIN currently prints -187.71% for profit margin, while the sector average sits near 14.34%. That is roughly 1408.5% below the sector mean. Large gaps often invite a closer look at Beauty Health Company (The)'s growth, margins, and balance sheet.
Profit Margin shows how effectively Beauty Health Company (The) converts resources into returns. At -187.71%, SKIN may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting SKIN's profit margin (-187.71%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Beauty Health Company (The)'s profit margin against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.